Trial Details

Not Recruiting
Basic Information
Clinical ID c5218
Identifier ChiCTR2500098333
Trial Title A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study To Assess The Efficacy And Safety Of Induction And Maintenance Therapy With RO7790121 In Patients With Moderately To Severely Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions CD is a chronic, progressive inflammatory disease of the gastrointestinal tract, characterized by periods of relapse and remission, which can ultimately lead to bowel damage and disability. Most patients present with an inflammatory phenotype, but over t
Interventions Test group 1:500 mg IV at weeks 0, 2, 6, and 10, followed by 450mg SC every 4 weeks from week 12 to week 52 (Q4W);Test group 2:500 mg IV at weeks 0, 2, 6, and 10, followed by 150 mg SCQ4W from week 12 to week 52;Placebo group:Placebo IV at weeks 0, 2, 6,
Participant Information
Sponsor Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
City NULL
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT, TEENAGER
Study Design
Study Type Interventional study
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL